KaleBios Says It's Current On Its Financials After 10-Q Filing
KaloBios Pharmaceuticals Inc. , the company formerly majority owned by controversial biotech investor Martin Shkreli, said late Friday it has filed its outstanding 10-Q for the first quarter and the first six months of 2016.